New drug ABBV-519 enters first human tests for lupus and arthritis
NCT ID NCT07607964
First seen May 31, 2026 · Last updated Jun 17, 2026 · Updated 5 times
Summary
This early-stage study tests a single dose of ABBV-519 in 30 adults with moderate lupus or rheumatoid arthritis. Researchers will check how the drug moves through the body, how it affects immune cells, and whether it is safe. Participants will be followed for about a year to monitor side effects and immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advanced Quality Medical Research /ID# 279147
RECRUITINGOrland Park, Illinois, 60462, United States
-
Discovery Health Research Center /ID# 279691
RECRUITINGPlantation, Florida, 33317, United States
-
Epic Medical Research /ID# 279180
RECRUITINGRed Oak, Texas, 75154, United States
-
Finlay Medical Research - Greenacres /ID# 278380
RECRUITINGGreenacres City, Florida, 33467, United States
-
Solace Research /ID# 279155
RECRUITINGTustin, California, 92780, United States
-
UCLA Health West Medical Campus /ID# 282811
WITHDRAWNLos Angeles, California, 90095, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.